๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Fourth-year interim safety and patient outcomes from ESPRIT, a 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis


Book ID
122151974
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
53 KB
Volume
70
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES